Clinical trial
MOMENTUM 3 IDE Clinical Study Protocol
NCT02224755 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT02224755 |
|---|---|
| Title | MOMENTUM 3 IDE Clinical Study Protocol |
| Official title | Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3™ IDE Clinical Study Protocol |
| Acronym | HM3™ |
| Lead sponsor | Abbott Medical Devices, Industry |
| Collaborators | Thoratec Corporation Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Advanced Refractory Left Ventricular Heart Failure |
| Intervention type | Device |
| Interventions | HeartMate 3 LVAS, HeartMate II LVAS |
| Enrollment | 1,028 |
| Start date | Sep 2, 2014 |
| Primary completion | Sep 28, 2018 |
| Completion | Mar 26, 2019 |
| First posted | Aug 25, 2014 |
| Last update posted | Jun 27, 2022 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: